For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Healthequity Inc’s stock clocked out at $97.34, up 2.98% from its previous closing price of $94.52. In other words, the price has increased by $2.98 from its previous closing price. On the day, 1.29 million shares were traded. HQY stock price reached its highest trading level at $97.48 during the session, while it also had its lowest trading level at $94.32.
Ratios:
To gain a deeper understanding of HQY’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.92. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On March 25, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also lowered its target price recommendation from $120 to $115.
On December 04, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $126.Mizuho initiated its Outperform rating on December 04, 2024, with a $126 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 03 ’25 when Delano Ladd bought 970 shares for $100.87 per share.
James M. Lucania bought 2,375 shares of HQY for $239,571 on Jul 03 ’25. On Jul 03 ’25, another insider, Stephen Neeleman, who serves as the Officer of the company, bought 1,049 shares for $100.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 8417515008 and an Enterprise Value of 9878022144. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 70.85, and their Forward P/E ratio for the next fiscal year is 22.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.77 while its Price-to-Book (P/B) ratio in mrq is 3.97. Its current Enterprise Value per Revenue stands at 7.947 whereas that against EBITDA is 24.348.
Stock Price History:
The Beta on a monthly basis for HQY is 0.55, which has changed by 0.19523573 over the last 52 weeks, in comparison to a change of 0.10611236 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is -3.17%, while the 200-Day Moving Average is calculated to be 0.91%.
Shares Statistics:
It appears that HQY traded 1.04M shares on average per day over the past three months and 1002700 shares per day over the past ten days. A total of 86.71M shares are outstanding, with a floating share count of 84.52M. Insiders hold about 2.26% of the company’s shares, while institutions hold 107.90% stake in the company. Shares short for HQY as of 1749772800 were 5262496 with a Short Ratio of 5.07, compared to 1747267200 on 5817919. Therefore, it implies a Short% of Shares Outstanding of 5262496 and a Short% of Float of 7.049999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 12.0 analysts are dedicated to thoroughly evaluating and rating the performance of Healthequity Inc (HQY) in the stock market.The consensus estimate for the next quarter is $0.91, with high estimates of $0.96 and low estimates of $0.86.
Analysts are recommending an EPS of between $3.85 and $3.6 for the fiscal current year, implying an average EPS of $3.72. EPS for the following year is $4.41, with 12.0 analysts recommending between $4.55 and $4.25.
Revenue Estimates
In the current quarter, 13 analysts expect revenue to total $320.85M. It ranges from a high estimate of $327.24M to a low estimate of $313.56M. As of the current estimate, Healthequity Inc’s year-ago sales were $299.93MFor the next quarter, 13 analysts are estimating revenue of $319.9M. There is a high estimate of $326.19M for the next quarter, whereas the lowest estimate is $314.8M.
A total of 14 analysts have provided revenue estimates for HQY’s current fiscal year. The highest revenue estimate was $1.32B, while the lowest revenue estimate was $1.3B, resulting in an average revenue estimate of $1.31B. In the same quarter a year ago, actual revenue was $1.2BBased on 13 analysts’ estimates, the company’s revenue will be $1.42B in the next fiscal year. The high estimate is $1.46B and the low estimate is $1.4B.
